Howard Martin Temin

Howard Martin Temin passed away on November 9, 1994, at the age of 59, in Madison, Wisconsin. He died from lung cancer, despite being a lifelong non-smoker. Temin's death was a significant loss to the scientific community, as he was renowned for his innovative work in cancer research and virology. His discoveries, especially concerning retroviruses, had a profound impact on the scientific understanding of viral replication and cancer genetics.

Howard Temin was inducted into the National Academy of Sciences in 1994, in recognition of his significant contributions to the field of virology and molecular biology. As a member of this prestigious organization, Temin's work on reverse transcriptase and the interaction of viruses with cellular genomes was acknowledged as groundbreaking, influencing a generation of research in cancer and genetics. His induction underscored the lasting impact of his scientific discoveries.

In the mid-1980s, Howard Temin focused on the AIDS epidemic, using his expertise on retroviruses to study the virus's behavior and replication mechanisms. Although he was not directly involved in creating therapies, his foundational work on reverse transcriptase provided vital knowledge for the development of antiretroviral drugs. Temin's contributions were crucial for understanding HIV biology and directly impacted the strategies developed to combat the illness, thus supporting efforts to manage and treat AIDS.

In 1980, Howard Temin was elected as a fellow of the American Academy of Arts and Sciences. This election was a testament to his significant contributions to science, particularly his research on reverse transcriptase and retroviruses. Receiving this honor recognized Temin's innovative research and its influence on molecular biology, virology, and cancer research, highlighting his standing as a leading scientist in these fields.

Howard Temin, along with Renato Dulbecco and David Baltimore, was awarded the 1975 Nobel Prize in Physiology or Medicine for their discoveries concerning the interaction between tumour viruses and the genetic material of the cell. Temin's pioneering research led to the understanding of how certain viruses could induce cancer, specifically detailing how retroviruses carry their genetic information in RNA and convert it into DNA. This work laid the foundation for the molecular mechanisms of cancer and viral replication.

In 1974, during a period of rapid advancements in genetic engineering, Howard Temin was among the scientists advocating for guidelines and regulations concerning recombinant DNA research. He was deeply concerned about the potential risks associated with the manipulation of genetic material and worked with colleagues to urge the scientific community and governments to consider the ethical implications and safety protocols in genetic experiments. These efforts were pivotal in shaping policies for safe research practices.

In 1970, Howard Temin, along with David Baltimore, independently discovered the enzyme reverse transcriptase. This enzyme was found to synthesize DNA from an RNA template, which was critical in understanding retroviruses and their replication cycles. This groundbreaking work challenged the central dogma of molecular biology at the time, which stated that genetic information flows only in one direction from DNA to RNA to protein. Temin's discovery provided insight into how retroviruses, like HIV, replicate and integrated into host genomes.

In 1964, Howard Temin proposed the provirus hypothesis, which posited that some viruses incorporate their genetic material into the DNA of the host cell. This hypothesis was revolutionary and provided a theoretical basis for the later discovery of reverse transcriptase. Temin's hypothesis was based on his research with the Rous sarcoma virus and laid the groundwork for understanding how retroviruses could alter cellular genetics, leading to diseases like cancer.

In 1960, Howard Temin accepted a position at the University of Wisconsin-Madison. His work at the university was pivotal, as it was here that he conducted much of his research on retroviruses and cancer genes. Temin's research led to significant breakthroughs in understanding the molecular biology of cancer. His tenure at the university helped shape the future of virology and cancer research, and he became a central figure at the McArdle Laboratory for Cancer Research.

Howard Martin Temin was born on December 10, 1934, in Philadelphia, Pennsylvania, USA. He would grow up to become a renowned American geneticist and virologist noted for his discoveries in the field of cancer research and his work on the reverse transcriptase enzyme, which played a crucial role in understanding how retroviruses replicate their RNA into DNA. This work greatly contributed to advances in molecular biology and virology.